HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
Abstract: Temozolomide (TMZ) is an oral alkylating agent widely used in the treatment of refractory glioma. Its efficacy is limited, however, by poor cancer cell penetration and drug resistance. The present study, therefore, aimed to investigate whether hyperbaric...
A multistep approach to manage Fournier’s gangrene in a patient with unknown type II diabetes: surgery, hyperbaric oxygen, and vacuum-assisted closure therapy: a case report.
Abstract: Fournier's gangrene is an infectious necrotizing fasciitis of the perineum and genital regions and has a high mortality rate. It is a synergistic infection caused by a mixture of aerobic and anaerobic organisms and predisposing factors, including diabetes...
Clinical Trial – Hypobaria and Traumatic Pneumothorax
The purpose of this research is to see if people who have had a collapsed lung that has been
re-expanded can be safely taken to an elevation that a person might experience while in a
commercial airplane without having their lung partially collapse again, or have any symptoms
such as feeling short of breath or having oxygen levels in the blood decrease while at the
simulated altitude.
The investigators hypothesize that subjects who have had a collapsed lung that has been
re-expanded will not have any adverse symptoms or signs while subjected to a simulated
altitude of 8400 feet (565mm Hg) or 12650 ft (471mm Hg).